. Sequence relatedness between mycobacterial Pks15/1 orthologs and suspected catalytic Cys residue in the ketosynthase domain and Ser residue site of phosphopantetheinylation in the acyl carrier protein domain of Pks15/1. (a) Alignment of Pks15/1 orthologs. Conserved amino acids are highlighted in white font over black background. The motif GPxxxxxxxCxSxL, which is the active site consensus for PKS and FAS ketosynthase domains, is marked. 11 The predicted catalytic Cys residue in this motif is indicated by the red arrowhead. The 4´-phosphopantetheine attachment site DSL conserved motif (NCBI's Conserved Domain Database Pfam family identifier: PF00550P) in the acyl carrier protein domain with the Ser residue (red arrowhead) that is phosphopantetheinylated is marked. (b) Percentage of amino acid identity among Pks15/1 orthologs. Sequence alignments were carried out using the MegAlign module of DNASTAR Lasergene software package. Mb, M. bovis; Mk, M. kansasii; Ml, M. leprae; Mm, M. marinum; Mt, M. tuberculosis; and Mu, M. ulcerans. Only confirmed PGL-producing strains of species for which pks15/1 is available via http://www.ncbi.nlm.nih.gov, or via The J. Craig Venter Institute in the case of Mt strain 210 Pks15/1, are included in the alignment. Sequence Accession Numbers at http://www.ncbi.nlm.nih.gov/sites/entrez: Mb strain AF2122/97 Pks15/1 (Pks1), NP_856616.1; Mk ATCC 12478 Pks15/1, NZ_ACBV01000072.1; Ml strain TN Pks15/1, NP_301229.1; Mm strain M Pks15/1, YP_001850066.1; and Mu strain Agy99 Pks15/1, YP_905915.1. Figure S2 . Sfp-dependent phosphopantetheinylation of Pks15/1 and Pks15/1(S2039A) in vitro. Phosphopantetheinylation was assessed as incorporation of the biotinylated phosphopantetheinyl group derived from the CoA analog biotinyl-CoA (Avanti Polar Lipids) onto the proteins. The GelCode Bluestained sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE; 5%) and its parallel Western blot for analysis of biotinylated proteins are shown. Lanes: Wt, wild-type; Mut, mutant; M, molecular weight marker. Phosphopantetheinylation reactions, SDS-PAGE, and Western blot were carried out using standard protocols described in the Experimental Section of the manuscript. Briefly, phosphopantetheinyl transferase Sfp was utilized for protein phosphopantetheinylation. Phosphopantetheinylation reactions were quenched by addition of SDS-PAGE loading buffer and analyzed by SDS-PAGE and by Western blot to detect biotinylated proteins. Proteins were electrophoretically transferred from the polyacrylamide gel to a Hybond-P membrane (GE Healthcare). Biotinylated-phosphopantetheinyl group covalently incorporated onto the proteins was detected using a commercial mouse monoclonal anti-biotin-alkaline phosphatase conjugated antibody (Sigma-Aldrich). Colorimetric detection of biotinylated proteins was achieved using alkaline phosphatase BCIP/NBT liquid substrate system (Sigma-Aldrich).
A.2. Phosphopantetheinylation of Pks15/1 and Pks15/1(S2039A)

A.3. Mass spectrometry data
Figure S3 1a to 10a (in vitro system): MS spectra of compounds 1 to 10, respectively, shown in Figure 3a and Table 1 Figure S3 MS analysis was conducted as described in the Experimental Section of the manuscript.
Microwave-based reactions were performed on a CEM-Discover Microwave irradiator, using the dynamic heating mode with a power limit of 300 W and pressure limit of 17 psi. 1 H and 13 C NMR spectra were acquired on a Bruker DRX-500 spectrometer at 500 MHz for 1 H and 125
MHz for 13 C. Chemical shifts are expressed in parts per million downfield from tetramethylsilane (TMS), using either TMS or the solvent resonance as an internal standard 
Experimental procedures
12-(tert-butyldimethylsilyloxy)dodecan-1-ol (1)
To a 35 mL microwave reaction vessel was added 1,12-dodecanediol (2.02 g, 9.9 mmol), TBSCl 
12-(tert-butyldimethylsilyloxy)dodecanal (2)
Monoprotected diol 1 (527 mg, 1.7 mmol) was dissolved in 10 mL of dry dichloromethane. To this solution was added a solution of Dess-Martin periodinane (741 mg, 1.8 mmol) and acetic acid (10.2 mg, 0.17 mmol) in dichloromethane (2 mL). 8 The reaction was stirred at room temperature for 40 min, at which point the starting material completely disappeared, as indicated by TLC. The reaction was then diluted with diethylether (25 mL), followed by 1.3 M NaOH (5 mL). The resulting suspension was stirred at room temperature for 15 min, and then separated. 
4-(15-(tert-butyldimethylsilyloxy)pentadec-3-enyl)phenol (3)
To a -10 ˚C solution of 3-(4-(hydroxyphenyl)propyltriphenylphosphonium bromide 9 (601 mg, 
21-(4-hydroxyphenyl)henicosa-6,18-dienoic acid (6)
To a -10 ˚C solution of 5-carboxypentyltriphenylphosphonium bromide 10 for 15 min, a solution of aldehyde 5 (30 mg, 9.5 µmol) in THF (2.5 mL) was slowly added and the resulting mixture was stirred at -10 ˚C for 2.5 h. At that point, the reaction was quenched with ice cold 1.0 M HCl (aq.) and extracted with ethyl acetate. After drying (with Na 2 SO 4 ) and concentrating, the residue was purified by flash chromatography (4:1 ratio hexane in ethyl acetate, R f = 0.12). The pure product was a white crystalline solid (27 mg, 69%). 1 
Ethyl 21-(4-hydroxyphenyl)henicosanoate (7)
To a solution of diene 6 (27 mg, 64 µmol) in absolute ethanol (1 mL) was added palladium on activated carbon (10% wt, 8.2 mg), and the mixture was vigorously stirred at room temperature for 94 h under 1 atm of hydrogen. At that point, the solvent was evaporated and the crude material directly purified by flash chromatography (4:1 hexane in ethyl acetate, R f = 0.45). The pure product appeared as a white crystalline solid (11.0 mg, 42% (Table 1 and Figure S3) .
B.2. Protein purification
Pks15/1 and its mutant variants Pks15/1(C211A), Pks15/1(S2039A), and Pks15/1(C211A-S2039A) were expressed from plasmids pET28b-Pks15/1, pET28b-Pks15/1(C211A), pET28b-Pks15/1(S2039A), and pET28b-Pks15/1(C211A-S2039A), respectively. The construction of these and other plasmids used in this study is described below (Section B. To obtain Pks15/1 and Pks15/1(C211A) in their phosphopantetheinylated (holo) form, the proteins were coexpressed with Sfp using plasmid pSU20-Sfp as reported. 2, 6 For protein overproduction, the corresponding expression strains were cultured in Luria-Bertani ( using Amicon Ultra-15 centrifugal filter devices (Millipore), and buffer-exchanged with 100 mM sodium phosphate buffer (pH 7.2) using PD-10 desalting columns (GE Healthcare) ( Figure S5 ).
Additional purification steps (e.g., size exclusion chromatography) were not possible due to poor protein solubility and/or loss of enzymatic activity of Pks15/1 and its mutant variants. FadD22
and FadD22(S576A) were expressed in E. coli BL21(DE3) as IPTG-inducible, C-terminally hexahistidine-tagged proteins and purified by Ni
2+
-column chromatography using Ni-NTA Superflow resin as previously reported. 2 Holo-FadD22 was obtained by coexpression with Sfp using plasmid pSU20-Sfp as described earlier. 2 Purified proteins were flash-frozen in a dry iceethanol bath and stored at -80 °C. 
B.3. Construction of plasmids
Recombinant DNA manipulations were carried out using reported standard methods 1 and E. coli DH5α (Invitrogen) as a cloning host. pks15/1 mutant alleles were created using QuikChange
Site-Directed Mutagenesis Kit (Stratagene). All constructs were sequenced to verify fidelity.
DNA sequencing was conducted at Cornell University's Life Sciences Core Laboratories Center.
Plasmid constructions are outlined in Figure S6 . 
